Call us directly: +44 (0)7905 201857

Email us info@sehta.co.uk

Members log in

SEHTA Events

Please see below all the latest information on SEHTA Events

May 2018

London MedTech Banner

BigB2SME with Johnson & Johnson Innovation

 

SEHTA, GLA and MedCity would like to invite you to register your interest to attend the next MedTech London BigB2SME event, this time with Johnson & Johnson Innovation, which is designed to build bridges between small companies (including MedTech, University and NHS Technologists) and Johnson & Johnson Innovation.

Date: Thursday 3rd May

Venue: City Hall, London

Times: 10:00 – 15:00

Cost: Free of charge

Overview 

  • Do you want to understand more about how to work with multinational health technology companies?
  • Is a partnership or other commercial agreement with a large multinational company something you should consider to help develop your business?
  • Are you developing a technology, product or service in?

Orthopaedics – earlier interventions in degenerative diseases, e.g. osteoarthritis, osteoporosis, degenerative disc disease

General & orthopaedics – technologies to support pre-operative planning, intra-operative navigation and visualisation

Obesity – More durable interventions across the continuum, which also prevent or reduce morbidities of obesity

REGISTER YOUR INTEREST BUTTON

 

 

Please note places are limited and applications will be reviewed based on London-focus and offer.  Places will be confirmed no later than Friday 20th April.

 

Agenda

10:00 – 10:30  Registration and Refreshments

10:30 – 10:35  Welcome, Dr David Parry, CEO, SEHA

10:35- 10:40   Introduction to the Johnson & Johnson Innovation team

10:40 – 11:10  An overview of Johnson & Johnson Innovation including the Innovation Centres, JJDC and JLABs, Dr Mirren Mandalia, Senior Director, New Ventures & Transactions (Medical Devices), Johnson & Johnson Innovation

11:10- 11:40  Focus areas for Johnson & Johnson Medical Devices, Dr Mirren Mandalia, Senior Director, New Ventures & Transactions (Medical Devices), Johnson & Johnson Innovation

11:40 – 12:00  Q&A

12:00 – 15:00  Networking and Refreshments (Lunch is not being provided, but the Cafe at City Hall is available to buy lunch)

12:30 – 15:00 Pre-arranged 1:1 sessions with Johnson & Johnson representatives and selection for follow-up.  Each 1:1 session lasts for 15 mins and you can book your 1:1 slot when you register your interest.  Sessions available with:

  • Dr Mirren Mandalia, Senior Director, New Ventures & Transactions (Medical Devices),Johnson & Johnson Innovation
  • Dr Michael Ullmann, Innovation Director, Medical Devices DACH, Johnson & Johnson Innovation
  • Dr Nicoline Van Leersum, Innovation Director, Medical Devices Benelux, Johnson & Johnson Innovation

London MedTech Banner

Life Sciences Export Brexit Conference – 17 May

Please join SEHTA, GLA, and MedCity on Thursday 17 May at Hempsons, London for our latest Life Sciences Brexit Conference.

Date: Thursday 17th May 2018

Venue: Hempsons, 40 Villiers Street, London

Times: 10:00 – 14:00

Cost: Free of Charge to attend

Overview

  • to inform London MedTech SMEs about the opportunities to export their services/products to US, Germany, India, China and Denmark
  • to direct London MedTech SMEs to public sector support for export
  • 15 1:1 session with speaker(s) – available to book upon registration

Please note that places are limited and all applications will be reviewed. Confirmation for the event will be sent to you by Friday 4th May.

REGISTER YOUR INTEREST BUTTON

Agenda

10:00 – 10:30 – Registration & Refreshments

10:30 – 10:35 – Welcome & Introduction by Chair, Dr David Parry, CEO, SEHTA

10:35 – 10:50 – Legal and Regulatory Implications for MedTech SMEs – James Lawford Davies, Partner, Hempsons

10:50 – 11:05 – Export: Opportunities & support for MedTech SMEs – DiT view on the US, Germany & India – Rob Lewtas, Strategic Partnerships Manager, Department for International Trade

11:05- 11:20 – Export: Opportunities & support for MedTech SMEs – China – William Franklin, Founder & CEO, China Investors Club

11:20 – 11:35 – Refreshment Break

11:35 – 11:50 – Export: Opportunities & support for MedTech SMEs – Danish Embassy view – Katrine Skovly, Project Manager, Invest in Denmark, Danish Embassy

11:50 – 12:05 – Export: Opportunities & support for MedTech SMEs – London & Partners view – Jules Chappell, Director of International Trade & Investment, London & Partners

12:05 – 12:20 – Open Discussion– All participants

12:20 – 14:00 – Lunch, Networking & 1:1 sessions with speakers (bookable when you register)

 

Kindly supported by: Hempsons logo (large for use on documents)

 

June 2018

Psephos event bannerMedical Device Clinical Strategy & Requirements Workshop

 

Date: Wednesday 6 June

Venue: Hempsons, 40 Villiers Street, London WC2N 6NJ

Times: 11:00 – 15:10

Fee:  SEHTA Members Fee – £125 + VAT / SEHT Non-Members Fee – £175 + VAT (it’s free to join SEHTA – www.sehta.co.uk/membership)
You will be invoiced via SEHTA via PayPal. The organisers reserve the right to decline registrations based on review. All applicants will be notified by email if they have been accepted for a place no later than Monday 28th May.

REGISTER YOUR INTEREST BUTTON

Why attend
Clinical strategy, evidence and evaluation are central to product approval and market access. It’s a requirement of the new EU Medical Device Regulation (MDR: article 61) that a medical device company have a regulatory strategy and of the MDR and MEDDEV 2.7/1 rev 4 that the company have a clinical evaluation strategy.
In order to generate sales, organisations need to have thought through the clinical elements for market access as this will put them back months, if not years, if not understood and completed when initially gathering clinical evidence.
Companies need to be prepared and have solutions in place to address this and their ongoing clinical requirements. Getting your clinical strategy wrong will delay approval and also access.
Outcomes
  • Understand clinical strategy and how that fits within an overall company strategy
  • Understand the role of clinical investigations, evaluations, evidence and post market clinical follow ups
  • Understand how clinical evidence and the role of clinical strategy enables market access
  • Interact with fellow practitioners and presenters during the Q&A

Agenda

11:00 – 11:30 Registration

11:30 – 11:40 Welcome, Dr David Parry, CEO, SEHTA & Jacques du Preez, MD, Mosaic Surgical

11:40 – 12:20 Clinical Strategy & Q&A, Robin Stephens, CEO, Psephos Biomedica

12:20 – 13:00 Clinical Evaluation & Q&A, Dr Anna Guildford, Clinical Evaluation Specialist, Psephos Biomedica & Robin Stephens

13:00 – 13:40 Networking Lunch Break

13:40 – 14:20 Clinical Investigations & Q&A, Robin Stephens

14:20 – 15:00 Clinical Evidence for Market Access & Post Market & Q&A, Jacques du Preez & Neil Roberts, Medical Technology Advisor, SEHTA

15:00 – 15:10 Closing Remarks, Dr David Parry & Robin Stephens

 

SEHTA LOGO2018 SEHTA AGM & Annual Conference: Accessing the NHS – a guide for SMEs

Come along on Wednesday 13th June to join SEHTA at our 2018 AGM & Annual Conference.  This year’s theme is about Accessing the NHS and you also receive a copy of our new Accessing the NHS: a guide for SME’s (to be published in May), which is kindly supported by Hempsons

Date: Wednesday 13 June
Venue: Mary Sumner House, Westminster, London
Times: 14:15 – 17:30
Cost: FOC

Most health technology companies want to access the NHS and SMEs find this especially challenging.
The SEHTA team have spent over 10 years helping companies understand and access the NHS and have finally attempted to distil all this knowledge and experience into a unique document with some specialist help from the legal team at Hempsons.
Come along to receive your printed version of The SEHTA Review ‘Accessing the NHS: A Guide for SMEs’ alongside hearing the story from us, and from SMEs who have done it.
Please note only 2 delegates per company allowed
register now button
Agenda
14:15 – 14:30 – Registration & Refreshments
14:30 – 14:45 – Welcome, Introduction & SEHTA AGM & Overview of the 2018 Accessing the NHS Review – Nick Rodgers, Chair & Dr David Parry, CEO, SEHTA
14:45 – 15:00 – SMEs and the NHS – Dr Des Holden, Medical Director, Surrey & Sussex Healthcare NHS Trust
15:00 – 15:15 – Funding – Dr David Parry, CEO, SEHTA
15:15 – 15:30 – Protecting your innovation & introduction to regulations – James Lawford Davies, Partner, Hempsons
15:30 – 15:45 – Commercialisation – Dr Melissa Kapoor, COO & Neil Roberts, Medical Technology Advisor, SEHTA
15:45 – 16:00 – 35 CCGs and counting! – Colin Rees, CEO, Transforming Systems
16:00 – 16:15 – Topic and speaker TBC
16:16 – 17:30 – Networking Reception

Kindly supported by: Hempsons logo (large for use on documents)